MyAverix Finance
US · Healthcare
Krystal Biotech Inc (KRYS)
Biotechnology
Krystal Biotech Inc (KRYS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KRYS
Krystal Biotech Inc (KRYS) — FAQ
What is KRYS's P/E ratio?
The price-to-earnings (P/E) ratio for Krystal Biotech Inc (KRYS) is 18.00 (data as of 2026-03-24).
Does Krystal Biotech Inc pay a dividend?
Dividend yield is not available in the current snapshot for Krystal Biotech Inc (KRYS). Check the MyAverix Finance app for the latest dividend data.
What sector is Krystal Biotech Inc in?
Krystal Biotech Inc (KRYS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is KRYS listed on?
KRYS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.